Market Tracker

07/31 6:45pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

During the Trading Day
52.15 +0.99 / +1.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
52.30 +0.15 / +0.29%
 
Volume: 5.1K

Today’s Trading

Previous close51.16
Today’s open54.95
Day’s range50.73 - 54.95
Volume806,031
Average volume (3 months)583,007
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-151.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio13.6
Price/Sales7.15
Price/Book6.67

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.13+0.38%
ZSPHZS Pharma Inc+0.91+1.55%
IRWDIronwood Pharmaceuti...-0.02-0.19%
EGRXEagle Pharmaceutical...-0.16-0.17%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts